Simplex Trading, LLC Xeris Biopharma Holdings, Inc. Transaction History

Simplex Trading, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$1.48 - $2.64 $277,241 - $494,538	-187,325 Reduced 97.88%	4,056 $6,000
Q1 2022 May 02, 2022	SELL	$2.0 - $2.87 $260,028 - $373,140	-130,014 Reduced 40.45%	191,381 $489,000
Q4 2021 Feb 23, 2022	BUY	$1.8 - $2.93 $555,238 - $903,805	308,466 Added 2385.85%	321,395 $941,000
Q4 2021 Feb 04, 2022	BUY	$1.8 - $2.93 $23,272 - $37,881	12,929 New	12,929 $53,000

141

59.9M

148K

45.7K

Ticker XERS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,956,992
Market Cap $416M
Description
Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.